Curry Webb Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
2,140
-6
-0.3% -$6.13K 1.06% 23
2026
Q1
$1.97M Sell
2,146
-115
-5% -$117K 0.93% 27
2025
Q4
$2.43M Buy
+2,261
New +$2.16M 1.21% 27

Other funds holding LLY

Curry Webb Wealth Management's LLY Position: Q2 2026 in Review

Curry Webb Wealth Management reduced its Eli Lilly (LLY) stake by 0.28% in Q2 2026, selling an estimated $6.13K and leaving 2,140 shares worth $2.57M. The position accounts for 1.06% of the portfolio, ranked #23.

Curry Webb Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Curry Webb Wealth Management held 2,140 shares of Eli Lilly worth $2.57M as of Q2 2026.
  • Curry Webb Wealth Management sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 1.06% of Curry Webb Wealth Management's portfolio in Q2 2026, its #23 holding.
  • Curry Webb Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Curry Webb Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.